Electrum1
Bluelighter
- Joined
- Nov 22, 2021
- Messages
- 28,905
VKTX became worth more because their diabetes drug is a GLP-1 drug that caught the market by surprise, and it could be better than Ozempic/Wegovy. They were the competitor of MDGL in NASH but moved ahead in market cap because now their other drug is good for overall fat loss and so on